Daratumumab increases PFS in patients with transplant-ineligible multiple myeloma

Bookmark and Share
Published: 6 Dec 2018
Views: 695
Rating:
Save
Prof Thierry Facon - Hôpital Claude Huriez, Lille, France

Dr Thierry Facon gives a press conference at ASH 2018 about the use of daratumumab in transplant-ineligible multiple myeloma patients.

Watch his interview with ecancer here.

Read more about this work here